<?xml version="1.0" encoding="UTF-8"?><rss version="2.0">
    <channel>
    <title>PM Live RSS Feed :: News &amp; Features</title>
 <link>http://www.pmlive.com</link>
        <description>PM Live RSS Feed :: News &amp; Features</description>
        <language>en-gb</language>
        
		<item>
  <title>AZ’s UK research job losses ‘bad news’ for country’s industry say unions</title>
  <link>http://www.pmlive.com/pharma_news/az_uk_job_losses_chesire_361251</link>
  <description><![CDATA[ GMB and Unite say 350 job cuts in R&amp;D at Chesire facility will damage UK industry, although ABPI remains optimistic]]></description>
  <pubDate>Fri, 03 Feb 2012 11:28:47 +0000</pubDate>
  <guid>http://www.pmlive.com/pharma_news/az_uk_job_losses_chesire_361251</guid>
</item> <item>
  <title>Victoza drives Novo Nordisk growth in 2011</title>
  <link>http://www.pmlive.com/pharma_news/victoza_novo_nordisk_financial_results_2011_361239</link>
  <description><![CDATA[Diabetes portfolio encourages 12 per cent increase in revenues for Denmark-based firm]]></description>
  <pubDate>Fri, 03 Feb 2012 10:02:28 +0000</pubDate>
  <guid>http://www.pmlive.com/pharma_news/victoza_novo_nordisk_financial_results_2011_361239</guid>
</item> <item>
  <title>Merck returns to profit in Q4</title>
  <link>http://www.pmlive.com/pharma_news/merck_financial_results_2011_361238</link>
  <description><![CDATA[Gains in diabetes division, but generics pose threat for 2012]]></description>
  <pubDate>Fri, 03 Feb 2012 09:53:53 +0000</pubDate>
  <guid>http://www.pmlive.com/pharma_news/merck_financial_results_2011_361238</guid>
</item> <item>
  <title>Mitchell Gold steps down as CEO and president of Dendreon</title>
  <link>http://www.pmlive.com/pharma_news/mitchell_gold_john_johson_ceo_president_dendreon_361218</link>
  <description><![CDATA[Former Savient CEO and Lilly senior VP John Johnson replaces Gold who remains at Dendreon as executive chair<BR>]]></description>
  <pubDate>Fri, 03 Feb 2012 07:03:15 +0000</pubDate>
  <guid>http://www.pmlive.com/pharma_news/mitchell_gold_john_johson_ceo_president_dendreon_361218</guid>
</item> <item>
  <title>EMA prepares for major changes to European pharmacovigilance legislation</title>
  <link>http://www.pmlive.com/pharma_news/european_pharmacovigilance_legislation_launch_july_2012_361201</link>
  <description><![CDATA[
New measures will encourage greater transparency and allow patients in any European Member State to report adverse reactions]]></description>
  <pubDate>Fri, 03 Feb 2012 07:03:04 +0000</pubDate>
  <guid>http://www.pmlive.com/pharma_news/european_pharmacovigilance_legislation_launch_july_2012_361201</guid>
</item> <item>
  <title>Caudex Medical makes senior hires</title>
  <link>http://www.pmlive.com/pharma_news/caudex_medical_andy_bowman_gary_burd_361217</link>
  <description><![CDATA[Appoints Andy Bowman and Gary Burd ]]></description>
  <pubDate>Fri, 03 Feb 2012 06:48:34 +0000</pubDate>
  <guid>http://www.pmlive.com/pharma_news/caudex_medical_andy_bowman_gary_burd_361217</guid>
</item> <item>
  <title>Major pharma deals during 2011</title>
  <link>http://www.pmlive.com/pharma_news/pharma_deal_watch_360166</link>
  <description><![CDATA[Deal watch: A look at the biggest mergers and acquisitions from 2011, including Sanofi's purchase of Genzyme and J&amp;J taking over Synthes]]></description>
  <pubDate>Fri, 03 Feb 2012 06:46:59 +0000</pubDate>
  <guid>http://www.pmlive.com/pharma_news/pharma_deal_watch_360166</guid>
</item> <item>
  <title>AstraZeneca to cut 7,300 jobs in global restructuring</title>
  <link>http://www.pmlive.com/pharma_news/astrazeneca_cut_7,300_jobs_global_restructure_360886</link>
  <description><![CDATA[Sales, research and supply chain operations among those affected ]]></description>
  <pubDate>Thu, 02 Feb 2012 11:15:02 +0000</pubDate>
  <guid>http://www.pmlive.com/pharma_news/astrazeneca_cut_7,300_jobs_global_restructure_360886</guid>
</item> <item>
  <title>Pfizer recalls contraceptive pills after packaging blunder</title>
  <link>http://www.pmlive.com/pharma_news/pfizer_recalls_contraceptive_pills_packaging_error_360939</link>
  <description><![CDATA[
One million packages of Lo/Ovral-28, Norgestrel and Ethinyl Estradiol voluntarily withdrawn in US after mix-up leads to risk of unwanted pregnancy]]></description>
  <pubDate>Thu, 02 Feb 2012 11:12:48 +0000</pubDate>
  <guid>http://www.pmlive.com/pharma_news/pfizer_recalls_contraceptive_pills_packaging_error_360939</guid>
</item> <item>
  <title>Personalised medicine for cystic fibrosis cleared in US</title>
  <link>http://www.pmlive.com/pharma_news/vertex_cystic_fibrosis_drug_Kalydeco_us_approval_360925</link>
  <description><![CDATA[Vertex'&nbsp;'breakthrough' Kalydeco is first treatment to target genetic mutation in the disease]]></description>
  <pubDate>Thu, 02 Feb 2012 10:10:22 +0000</pubDate>
  <guid>http://www.pmlive.com/pharma_news/vertex_cystic_fibrosis_drug_Kalydeco_us_approval_360925</guid>
</item> <item>
  <title>Abiraterone too expensive for NHS, says NICE</title>
  <link>http://www.pmlive.com/pharma_news/abiraterone_too_expensive_for_nhs,_says_nice_360887</link>
  <description><![CDATA[Price of J&amp;J's prostate cancer treatment too high to justify use in UK]]></description>
  <pubDate>Thu, 02 Feb 2012 10:04:06 +0000</pubDate>
  <guid>http://www.pmlive.com/pharma_news/abiraterone_too_expensive_for_nhs,_says_nice_360887</guid>
</item> <item>
  <title>Income up for Roche despite dip in sales</title>
  <link>http://www.pmlive.com/pharma_news/roche_income_increase_sales_fall_2011_financial_results_360861</link>
  <description><![CDATA[ Swiss firm looks to new products and purchase of Illumina to compensate for revenue decline]]></description>
  <pubDate>Thu, 02 Feb 2012 09:58:44 +0000</pubDate>
  <guid>http://www.pmlive.com/pharma_news/roche_income_increase_sales_fall_2011_financial_results_360861</guid>
</item> <item>
  <title>Dan Zabrowski takes over as head of Roche Applied Science</title>
  <link>http://www.pmlive.com/pharma_news/dan_zabrowski_head_roche_applied_science_360821</link>
  <description><![CDATA[ Former global head of partnering succeeds Paul Brown]]></description>
  <pubDate>Thu, 02 Feb 2012 09:51:18 +0000</pubDate>
  <guid>http://www.pmlive.com/pharma_news/dan_zabrowski_head_roche_applied_science_360821</guid>
</item> <item>
  <title>Pillars of success in market access</title>
  <link>http://www.pmlive.com/pharma_news/market_access_pillars_of_success_359577</link>
  <description><![CDATA[The key to true market access success begins with corporate ownership… ]]></description>
  <pubDate>Thu, 02 Feb 2012 06:47:11 +0000</pubDate>
  <guid>http://www.pmlive.com/pharma_news/market_access_pillars_of_success_359577</guid>
</item> <item>
  <title>Pfizer lost $5bn to generics in 2011</title>
  <link>http://www.pmlive.com/pharma_news/pfizer_Q4_results_lipitor_patent_360610</link>
  <description><![CDATA[Pharma giant’s fourth quarter hit particularly hard after Lipitor’s November US patent expiry<br>]]></description>
  <pubDate>Wed, 01 Feb 2012 11:34:33 +0000</pubDate>
  <guid>http://www.pmlive.com/pharma_news/pfizer_Q4_results_lipitor_patent_360610</guid>
</item>     </channel>
</rss>
